A new strategy in regenerative medicine could promote recovery from damage
Tissue regeneration researchers at IBEC, UB and the UPC have developed an implant that could aid the regeneration of brain tissue, particularly in cases of pre- and postnatal injury.
Researchers from IBEC and ISGlobal’s research centre CRESIB make a major breakthrough in the field of microengineered organs on chips
Scientists from the Institute of Bioengineering of Catalonia (IBEC) and ISGlobal’s research centre CRESIB have designed the first-ever functional 3D splenon capable of reproducing the function of the spleen, which is to filter red blood cells. To do this, they created a microscale platform that reproduces the physical and hydrodynamic properties of the functional unit of the splenic red pulp, the splenon. The device may serve to investigate potential drugs for malaria and other blood disorders. The study reporting the development was published in Lab on a Chip.
Drugs in nanocapsules ‘recognise’ the infected cells of different types of malaria and could help curb resistance
A study by researchers from the Institute for Bioengineering of Catalonia (IBEC) and the Barcelona Centre for International Health Research (CRESIB) demonstrates that an antimalarial drug encapsulated in nanoparticles—chloroquine salts in polyamidoamine polymers—is significantly more effective when delivered in vivo than free (unencapsulated) drugs and may help to curb drug resistance.
A paper by IBEC’s Signal and Information Processing for Sensing Systems group and their collaborators is the featured article and appears on the cover of the latest issue of Analytica Chimica Acta.
Results from IBEC researchers and their collaborators will pave the way for better and faster wound healing, as well opening new avenues for tissue engineering of skin
A researcher’s paper published in the journal Environmental Microbiology is just one step in the right direction to tackle a major public health issue that he and other experts say could soon be devastating.
Microbiologists led by Antonio Juárez at IBEC and their collaborators at the University of Barcelona reveal that a particular genetic element – a plasmid – that confers multiple antibiotic resistance plays a major role in the survival of Salmonella, the cause of typhoid fever in humans.
IBEC researchers have come up with a groundbreaking new approach to create a tough, biodegradable, bioactive and entirely new material, heralding a major milestone in the production of artificial matrices for tissue engineering.
In a letter published today in the Royal Society journal Interface, the Biomaterials for Regenerative Therapies group describes a new, easy and cheap method for producing glass-coated fibrous scaffolds which not only faithfully mimic the extracellular matrix of bone, but also aim to direct stem cell fate through physical and chemical interactions.
A new discovery about how cells move inside the body may provide scientists with crucial information about disease mechanisms such as the spread of cancer or the constriction of airways caused by asthma.
Researchers at IBEC and Harvard School of Public Health have found that epithelial cells—the type that form a barrier between the inside and the outside of the body, such as skin cells—move in a group, propelled by forces both from within and from nearby cells to fill any spaces they encounter.
Researchers at IBEC and IRB achieve photo-switchable molecules to control protein-protein interactions in a remote and non-invasive manner
These tools will serve as a prototype to develop photo-switchable drugs, whose effects would be limited to a given region and time, thus reducing the side effects on other regions.
Cookies
Cookie Consent The IBEC website uses cookies and similar technologies to ensure the basic functionality of the site and for statistical and optimisation purposes. It also uses cookies to display content such as YouTube videos that use marketing cookies. This last category consists of tracking cookies: these make it possible for your online behaviour to be tracked. You consent to this by clicking on Accept. Also read our Privacy statement.
Read our cookie policy